A G Protein-coupled Receptor Responsive to Bile Acids
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
So far some nuclear receptors for bile acids have been identified. However, no cell surface receptor for bile acids has yet been reported. We found that a novel G protein-coupled receptor, TGR5, is responsive to bile acids as a cell-surface receptor. Bile acids specifically induced receptor internalization, the activation of extracellular signal-regulated kinase mitogen-activated protein kinase, the increase of guanosine 5'-O-3-thio-triphosphate binding in membrane fractions, and intracellular cAMP production in Chinese hamster ovary cells expressing TGR5. Our quantitative analyses for TGR5 mRNA showed that it was abundantly expressed in monocytes/macrophages in human and rabbit. Treatment with bile acids was found to suppress the functions of rabbit alveolar macrophages including phagocytosis and lipopolysaccharide-stimulated cytokine productions. We prepared a monocytic cell line expressing TGR5 by transfecting a TGR5 cDNA into THP-1 cells that did not express TGR5 originally. Treatment with bile acids suppressed the cytokine productions in the THP-1 cells expressing TGR5, whereas it did not influence those in the original THP-1 cells, suggesting that TGR5 is implicated in the suppression of macrophage functions by bile acids.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, KO of the BA receptors FXR (Nr1h4), TGR5 (Gpbar1), and VDR (Vdr) (36-38) did not rescue T cell function in LCA-fed mice (fig. S10, F and G).”
From Bile acid synthesis impedes tumor-specific T cell responses during liver cancer (2025) · cites this paper as [36]
In the citing paper
“activation of GPBAR1 on macrophages and Kupffer cells by synthetic agonists inhibits the expression of LPS-induced pro-inflammatory cytokines by interfering with NF-κB-dependent transcription.”
From Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System (2017) · cites this paper as Kawamata et al., 2003
In the citing paper
“Both receptors can be activated by primary and secondary bile acids alike (Kawamata et al., 2003; Makishima et al., 1999; Maruyama et al., 2002; Parks et al., 1999; H. Wang et al., 1999).”
From Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System (2017) · cites this paper as Kawamata et al., 2003
In the citing paper
“GPBAR1, as the name suggests, is a Gs-protein-coupled receptor. Binding by bile acids triggers an increase in intracellular cAMP levels and the activation of ERK (Kawamata et al., 2003; Maruyama et al., 2002).”
From Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System (2017) · cites this paper as Kawamata et al., 2003
In the citing paper
“This has been linked to direct inhibition of NF-κB activation, but is also consistent with a model of transcriptional competition between NF-κB and the cAMP-activated transcription factor cAMP response element binding protein (CREB) (C. Guo et al., 2015; Kawamata et al., 2003; Keitel et al., 2008; Pols et al., 2011; Y.-D. Wang et al., 2011; Wen et al., 2010).”
From Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System (2017) · cites this paper as Kawamata et al., 2003
6 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
1 retracted
Sphingosylphosphorylcholine is a ligand for ovarian cancer G-protein-coupled receptor 1
Xu, Y., Zhu, K., Hong, G., Wu, W., Baudhuin, L. M., Xiao, Y.-J., & Damron, D. S. (2000) · Nature Cell Biology · doi:10.1038/35010529 · Cited by 289
RetractedCD14, a Receptor for Complexes of Lipopolysaccharide (LPS) and LPS Binding Protein
Wright, S. D., Ramos, R. A., Tobias, P. S., Ulevitch, R. J., & Mathison, J. C. (1990) · Science · doi:10.1126/science.1698311 · Cited by 3,987
Identification of a nuclear receptor for bile acids
Makishima, M., Okamoto, A. Y., Repa, J. J., Tu, H., Learned, R. M., Luk, A., Hull, M. V., Lustig, K. D., Mangelsdorf, D. J., & Shan, B. (1999) · Science · doi:10.1126/science.284.5418.1362 · Cited by 2,714
Bile Acids: Natural Ligands for an Orphan Nuclear Receptor
Parks, D. J., Blanchard, S. G., Bledsoe, R. K., Chandra, G., Consler, T. G., Kliewer, S. A., Stimmel, J. B., Willson, T. M., Zavacki, A. M., Moore, D. D., et al. (1999) · Science · doi:10.1126/science.284.5418.1365 · Cited by 2,274
SOSUI: classification and secondary structure prediction system for membrane proteins.
Hirokawa, T., Boon-Chieng, S., & Mitaku, S. (1998) · Bioinformatics · doi:10.1093/bioinformatics/14.4.378 · Cited by 1,936
An oxysterol signalling pathway mediated by the nuclear receptor LXRα
Janowski, B. A., Willy, P. J., Devi, T. R., Falck, J. R., & Mangelsdorf, D. J. (1996) · Nature · doi:10.1038/383728a0 · Cited by 1,591
The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity
Staudinger, J. L., Goodwin, B., Jones, S. A., Hawkins-Brown, D., MacKenzie, K. I., LaTour, A., Liu, Y., Klaassen, C. D., Brown, K. K., Reinhard, J., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051551698 · Cited by 1,379
A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis
Yokomizo, T., Izumi, T., Chang, K., Takuwa, Y., & Shimizu, T. (1997) · Nature · doi:10.1038/42506 · Cited by 971
Russell, D. W., & Setchell, K. D. R. (1992) · Biochemistry · doi:10.1021/bi00135a001 · Cited by 819
The Pregnane X Receptor: A Promiscuous Xenobiotic Receptor That Has Diverged during Evolution
Jones, S. A., Moore, L. B., Shenk, J. L., Wisely, G. B., Hamilton, G. A., McKee, D. D., Tomkinson, N. C. O., LeCluyse, E. L., Lambert, M. H., Willson, T. M., et al. (2000) · Molecular Endocrinology · doi:10.1210/me.14.1.27 · Cited by 672
Research works printed but not linked: 3
- Jones, 2000, Mol. Endocrinol., 14, 27, 10.1210/mend.14.1.0409 · doi:10.1210/mend.14.1.0409 · Paper page
- Keane, 1984, Surgery, 95, 439
- Kimmings, 1995, J. Am. Coll. Surg., 181, 567
Cited by
Items 401–500 of 1,002
Bile acid receptors and nonalcoholic fatty liver disease
Yuan, L. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i28.2811 · Cited by 82
The bile steroid chenodeoxycholate is a potent antagonist at NMDA and GABAA receptors
Schubring, S. R., Fleischer, W., Lin, J. S., Haas, H. L., & Sergeeva, O. A. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2011.11.036 · Cited by 81
“As cholate and CDCA are potent ligands of the BS receptor TGR5 [4], which is expressed in the brain [6], we tested the effects under maximal activation of the TGR5-mediated signal cascade.”
BackgroundChang, S., Kim, Y.-H., Kim, Y.-J., Kim, Y., Moon, S., Lee, Y. Y., Jung, J. S., Kim, Y., Jung, H.-E., Kim, T.-J., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01984 · Cited by 83
“The EC50 of deoxycholic acid (DCA) to increase cAMP production in a TGR5-dependent manner was 1μM (26).”
BackgroundMethodInfluentialLi, X.-Y., Zhang, S.-Y., Hong, Y.-Z., Chen, Z.-G., Long, Y., Yuan, D.-H., Zhao, J., Tang, S., Wang, H., & Hong, H. (2024) · Neuron · doi:10.1016/j.neuron.2024.02.019 · Cited by 86
Role of bile acids in the regulation of the metabolic pathways
Taoka, H., Yokoyama, Y., Morimoto, K., Kitamura, N., Tanigaki, T., Takashina, Y., Tsubota, K., & Watanabe, M. (2016) · World Journal of Diabetes · doi:10.4239/wjd.v7.i13.260 · Cited by 80
Differential effects of FXR or TGR5 activation in cholangiocarcinoma progression
Erice, O., Labiano, I., Arbelaiz, A., Santos‐Laso, Á., Muñoz-Garrido, P., Jiménez-Agüero, R., Olaizola, P., Caro‐Maldonado, A., Martín-Martín, N., Carracedo, A., et al. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.08.016 · Cited by 86
Bile acid-mediated signaling in cholestatic liver diseases
Zeng, J., Fan, J., & Zhou, H. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01035-1 · Cited by 84
Briere, D. A., Ruan, X., Cheng, C. C., Siesky, A. M., Fitch, T. E., Dominguez, C., Sanfeliciano, S. G., Montero, C., Suen, C. S., Xu, Y., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0136873 · Cited by 78
“Recently, new insights into the biological activity of bile acids have been revealed, including the discovery of a Gs-protein coupled receptor designated TGR5 [13,14].”
BackgroundCasaburi, I., Avena, P., Lanzino, M., Sisci, D., Giordano, F., Maris, P., Catalano, S., Morelli, C., & Andò, S. (2012) · Cell Cycle · doi:10.4161/cc.21029 · Cited by 79
“More recently, in addition to their genomic action, BAs have also been shown to be able to induce rapid non-genomic signaling pathways through the activation of a novel plasma membrane G protein-coupled receptor, TGR5, also known as M-BAR or BG37.”
BackgroundInfluentialReverse Genetics System for Porcine Enteric Calicivirus, a Prototype Sapovirus in the Caliciviridae
Chang, K., Sosnovtsev, S. S., Belliot, G., Wang, Q., Saif, L. J., & Green, K. Y. (2005) · Journal of Virology · doi:10.1128/jvi.79.3.1409-1416.2005 · Cited by 80
“Recent studies indicate that bile acids not only play an essential role as carriers of dietary lipids for absorption but also may function as hormone-like regulatory molecules with specific cellular receptors (14, 15, 21).”
BackgroundMolecular Regulation of Bile Acid Homeostasis
Choudhuri, S., & Klaassen, C. D. (2021) · Drug Metabolism and Disposition · doi:10.1124/dmd.121.000643 · Cited by 82
Kim, Y. S., Hurley, E., Park, Y., & Ko, S. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01042-9 · Cited by 94
Specific bile acids inhibit hepatic fatty acid uptake in mice
Nie, B., Park, H. M., Kazantzis, M., Lin, M., Henkin, A. H., Ng, S. M., Song, S., Chen, Y., Tran, H., Lai, R., et al. (2012) · Hepatology · doi:10.1002/hep.25797 · Cited by 83
The impact of sterile inflammation in acute liver injury
Department of Pharmacology, T. &. T., & Woolbright, B. (2017) · Journal of Clinical and Translational Research · doi:10.18053/jctres.03.2017s1.003 · Cited by 77
“When hepatocytes are exposed to sufficient concentrations of specific bile acids, they can undergo a variety of changes including apoptosis [218], necrosis [51,219], dramatic upregulation of cytokines such as MIP-2 and mKC [25], and activation of signaling pathways through G-protein coupled bile acid receptor (TGR) an…”
BackgroundRoth, J. D., Feigh, M., Veidal, S. S., Fensholdt, L. K., Rigbolt, K. T., Hansen, H. H., Chen, L. C., Petitjean, M., Friley, W., Vrang, N., et al. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i2.195 · Cited by 75
Jin, P., Deng, S., Tian, M., Lenahan, C., Wei, P., Wang, Y., Tan, J., Wen, H., Zhao, F., Gao, Y., et al. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113504 · Cited by 85
Bile acids in immunity: Bidirectional mediators between the host and the microbiota
Godlewska, U., Bulanda, E., & Wypych, T. P. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.949033 · Cited by 82
“Agonists of two bile acid receptors, TGR5 (GPBAR1) and FXR, have attracted the most attention as drug candidates, and their efficacy in preclinical models of colitis has been widely described (38–42).”
BackgroundInfluentialHodge, R. J., Lin, J., Vasist Johnson, L. S., Gould, E. P., Bowers, G. D., Nunez, D. J., & on behalf of the SB‐756050 Project Team (2013) · Clinical Pharmacology in Drug Development · doi:10.1002/cpdd.34 · Cited by 75
Ginos, B. N. R., Navarro, S. L., Schwarz, Y., Gu, H., Wang, D., Randolph, T. W., Shojaie, A., Hullar, M. A. J., Lampe, P. D., Kratz, M., et al. (2018) · Metabolism · doi:10.1016/j.metabol.2018.02.006 · Cited by 79
“TCA and GCA can also activate TGR5, but to a lesser extent [24].”
BackgroundWang, J., Zhang, J., Lin, X., Wang, Y., Wu, X. Y., Yang, F., Gao, W. D., Zhang, Y., Sun, J., Jiang, C., et al. (2020) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2020.10.014 · Cited by 77
Plasma bile acids are not associated with energy metabolism in humans
Brufau, G., Bahr, M. J., Staels, B., Claudel, T., Ockenga, J., Böker, K. H., Murphy, E. J., Prado, K., Stellaard, F., Manns, M. P., et al. (2010) · Nutrition & Metabolism · doi:10.1186/1743-7075-7-73 · Cited by 73
“Other studies confirmed these results [12] and indicated that the gallbladder is actually the primary site of Gpbar1 expression [13].”
BackgroundResultInfluentialBaptissart, M., Vega, A., Martinot, E., Pommier, A. J., Houten, S. M., Marceau, G., de Haze, A., Baron, S., Schoonjans, K., Lobaccaro, J.-M. A., et al. (2014) · Hepatology · doi:10.1002/hep.27204 · Cited by 65
Fuchs, C. D., Paumgartner, G., Mlitz, V., Kunczer, V., Halilbasic, E., Leditznig, N., Wahlström, A., Ståhlman, M., Thüringer, A., Kashofer, K., et al. (2018) · Gut · doi:10.1136/gutjnl-2017-314553 · Cited by 76
MahmoudianDehkordi, S., Bhattacharyya, S., Brydges, C. R., Jia, W., Fiehn, O., Rush, A. J., Dunlop, B. W., & Kaddurah-Daouk, R. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.937906 · Cited by 75
Microbiome, bile acids, and obesity: How microbially modified metabolites shape anti‐tumor immunity
Sipe, L. M., Chaib, M., Pingili, A. K., Pierre, J. F., & Makowski, L. (2020) · Immunological Reviews · doi:10.1111/imr.12856 · Cited by 78
Zhao, L., Zhang, H., Liu, X., Xue, S., Chen, D., Zou, J., & Jiang, H. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.07.011 · Cited by 79
Immunomodulatory functions of FXR
Fiorucci, S., Zampella, A., Ricci, P., Distrutti, E., & Biagioli, M. (2022) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2022.111650 · Cited by 70
Sonne, D. P., Hansen, M., & Knop, F. K. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0154 · Cited by 75
Arrhythmia risk in liver cirrhosis
Mozos, I. M. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i4.662 · Cited by 75
Recent Progress on Bile Acid Receptor Modulators for Treatment of Metabolic Diseases
Xu, Y. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00342 · Cited by 77
Regulation of bile acid receptor activity
Wan, Y. Y., & Sheng, L. (2018) · Liver Research · doi:10.1016/j.livres.2018.09.008 · Cited by 83
Yang, J. I., Yoon, J., Myung, S. J., Gwak, G., Kim, W. K., Chung, G. E., Lee, S. H., Lee, S., Kim, C. Y., & Lee, H.-S. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.07.001 · Cited by 80
Chen, L., McNulty, J. A., Anderson, D., Liu, Y., Nystrom, C., Bullard, S., Collins, J. L., Handlon, A. L., Klein, R. R., Grimes, A. M., et al. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.166892 · Cited by 80
“Physical retention of more bile acids in the lumen of the intestine may modulate the binding and activation of the G-protein-coupled bile acid receptor TGR5 (Kawamata et al., 2003).”
BackgroundPlasma Bile Acids Are Associated with Energy Expenditure and Thyroid Function in Humans
Ockenga, J., Valentini, L., Schuetz, T., Wohlgemuth, F., Glaeser, S., Omar, A., Kasim, E., duPlessis, D., Featherstone, K., Davis, J. R., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2329 · Cited by 70
“This mechanism may be severely impaired in TSHoma cells in which TGR-5 may either be internalized as described before in a cell model after stimulation with taurolithocholic acid (17) or may be incorrectly processed and is thus not expressed in the membrane.”
BackgroundMethodInfluentialEblimit, Z., Thevananther, S., Karpen, S. J., Taegtmeyer, H., Moore, D. D., Adorini, L., Penny, D. J., & Desai, M. S. (2018) · Cardiovascular Therapeutics · doi:10.1111/1755-5922.12462 · Cited by 80
The potential role of mitochondria in the microbiota-gut-brain axis: Implications for brain health
Qiao, L., Yang, G., Wang, P., & Xu, C. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107434 · Cited by 78
The relationship between postprandial bile acid concentration, GLP‐1, PYY and ghrelin
Roberts, R. E., Glicksman, C., Alaghband‐Zadeh, J., Sherwood, R. A., Akuji, N., & le Roux, C. W. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03886.x · Cited by 70
Cao, R., Cronk, Z. X., Zha, W., Sun, L., Wang, X., Fang, Y., Studer, E. J., Zhou, H., Pandak, W. M., Dent, P., et al. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m004929 · Cited by 79
Walther, B., Lett, A. M., Bordoni, A., Tomás‐Cobos, L., Nieto, J. A., Dupont, D., Danesi, F., Shahar, D. R., Echaniz, A., Re, R., et al. (2019) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201900677 · Cited by 77
Yang, Z., Kusumanchi, P., Ross, R. A., Heathers, L., Chandler, K., Oshodi, A., Thoudam, T., Li, F., Wang, L., & Liangpunsakul, S. (2019) · Hepatology Communications · doi:10.1002/hep4.1322 · Cited by 74
“(26,32) BAs also act as the ligands for the G protein-coupled receptor (GPCR) TGR5.(33) Once activated, TGR5 stimulates the release of GLP-1 from enterochromaffin L cells in the intestine.”
BackgroundBile acid receptors and signaling crosstalk in the liver, gut and brain
Ferrell, J. M., & Chiang, J. Y. L. (2021) · Liver Research · doi:10.1016/j.livres.2021.07.002 · Cited by 77
Wang, X. X., Xie, C., Libby, A. E., Ranjit, S., Levi, J., Myakala, K., Bhasin, K., Jones, B. A., Orlicky, D. J., Takahashi, S., et al. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102530 · Cited by 75
“TGR5 is activated by bile acids, with the secondary bile acid lithocholic acid (LCA) and its tauro-conjugate (T-LCA) being the most potent endogenous agonists (16-18).”
BackgroundGrozovsky, R., Ribich, S., Rosene, M. L., Mulcahey, M. A., Huang, S. A., Patti, M. E., Bianco, A. C., & Kim, B. W. (2009) · Endocrinology · doi:10.1210/en.2008-0938 · Cited by 72
Liaset, B., Hao, Q., Jørgensen, H., Hallenborg, P., Du, Z.-Y., Ma, T., Marschall, H.-U., Kruhøffer, M., Li, R., Li, Q., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.234732 · Cited by 72
Wu, X., Lv, Y.-G., Du, Y.-F., Hu, M., Reed, M. N., Long, Y., Suppiramaniam, V., Hong, H., & Tang, S.-S. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.08.016 · Cited by 72
“homeostasis, and glucose metabolism (Kawamata et al., 2003).”
Gastroesophageal reflux and lung transplantation
D’Ovidio, F., & Keshavjee, S. H. (2006) · Diseases of the Esophagus · doi:10.1111/j.1442-2050.2006.00603.x · Cited by 75
Gut Microbiota‐Bile Acid Crosstalk in Diarrhea‐Irritable Bowel Syndrome
Zhan, K., Zheng, H., Jian-qing, L., Wu, H., Qin, S., Luo, L., & Huang, S. (2020) · BioMed Research International · doi:10.1155/2020/3828249 · Cited by 79
“While the rank order of TGR5 is different, one is LCA>DCA>CDCA>CA for unconjugated BAs [76], the other is TLCA>LCA>GLCA>TDCA>DCA>GDCA> TCDCA>CDCA>GCDCA>TCA>CA>GCA for both conjugated and unconjugated BAs [77].”
BackgroundBile acids regulation of cellular stress responses in liver physiology and diseases
Li, T., Hasan, M. N., & Gu, L. (2024) · eGastroenterology · doi:10.1136/egastro-2024-100074 · Cited by 83
“48 49 In bariatric surgery, postoperation elevation of circulating bile acids are generally thought to contribute to the rapid improvement of insulin sensitivity.”
Enhancement of genotype 1 hepatitis C virus replication by bile acids through FXR
Scholtès, C., Diaz, O., Icard, V., Kaul, A., Bartenschlager, R. F. W., Lotteau, V., & André, P. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.09.015 · Cited by 74
The cholangiocyte primary cilium in health and disease
Mansini, A. P., Peixoto, E., Thelen, K. M., Gaspari, C. I., Jin, S., & Gradilone, S. A. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.06.006 · Cited by 79
“TGR5 is activated by unconjugated and conjugated bile acids in the order of taurolithocholic acid (TLCA) > lithocholic acid (LCA) > deoxycholic acid (DCA) > chenodeoxycholic acid (CDCA) > cholic acid (CA) and participates in the regulation of the bile acid pool, bile composition, modulation of hepatic inflammation and…”
BackgroundSatiety induced by bile acids is mediated via vagal afferent pathways
Wu, X., Li, J., Lee, A. A., Lu, Y., Zhou, S.-Y., & Owyang, C. (2020) · JCI Insight · doi:10.1172/jci.insight.132400 · Cited by 77
“It is well known that BA may act on membrane TGR5 receptors (1, 2) as well as several nuclear hormone receptors, including FXRα and PRX (26–28).”
BackgroundCarino, A., Biagioli, M., Marchianò, S., Fiorucci, C., Zampella, A., Monti, M. C., Scarpelli, P. T., Ricci, P., Distrutti, E., & Fiorucci, S. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2019.07.006 · Cited by 72
Impact of Fecal Microbiota Transplantation on Gut Bacterial Bile Acid Metabolism in Humans
Bustamante, J.-M., Dawson, T., Loeffler, C., Marfori, Z., Marchesi, J. R., Mullish, B. H., Thompson, C. C., Crandall, K. A., Rahnavard, A., Allegretti, J. R., et al. (2022) · Nutrients · doi:10.3390/nu14245200 · Cited by 76
Yang, J., Tang, X., Zhu, L., Chen, M., & Sun, L. (2023) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2022.0327 · Cited by 74
“2) and is activated by unconjugated bile acids.(17,18) Our previous study showed that S1PR2 is the predominant S1PR in hepatocytes and cholangiocytes and that S1PR2 mediates TCA-induced cholangiocyte proliferation.”
Gu, F., Zhu, S., Tang, Y., Liu, X., Jia, M., Malmuthuge, N., Valencak, T. G., McFadden, J. W., Liu, J., & Sun, H. (2023) · Microbiome · doi:10.1186/s40168-023-01492-3 · Cited by 76
Jäntti, S. E., Kivilompolo, M., Öhrnberg, L., Pietiläinen, K. H., Nygrén, H., Orešič, M., & Hyötyläinen, T. (2014) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-014-8230-9 · Cited by 74
Keely, S. J., Scharl, M. M., Bertelsen, L. S., Hagey, L. R., Barrett, K. E., & Hofmann, A. F. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00076.2006 · Cited by 73
“Bile acids have also been found to have the ability to elicit cellular responses through interactions with G-protein-coupled receptors (16, 21), particularly the muscarinic M3 receptor, in some experimental systems (27).”
BackgroundBile acid-activated receptors and the regulation of macrophages function in metabolic disorders
Fiorucci, S., Baldoni, M., Ricci, P., Zampella, A., Distrutti, E., & Biagioli, M. (2020) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2020.04.008 · Cited by 73
Maczewsky, J., Kaiser, J., Gresch, A., Gerst, F., Düfer, M., Krippeit‐Drews, P., & Drews, G. (2018) · Diabetes · doi:10.2337/db18-0315 · Cited by 69
“The Gas subunit is known to activate adenylyl cyclase (AC), which leads to cAMP production (3).”
BackgroundBile Acid and Gut Microbiota in Irritable Bowel Syndrome
Min, Y. W., Rezaie, A. R., & Pimentel, M. (2022) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm22129 · Cited by 74
“TGR5 is a member of the G protein-coupled receptor family, which stimulates cAMP synthesis and activates protein kinase-A, leading to the expression of target genes.(87) TGR5”
BackgroundInfluentialGut Metabolites Acting on the Gut-Brain Axis: Regulating the Functional State of Microglia
Deng, W., Yi, P., Xiong, Y., Ying, J., Lin, Y., Dong, Y., Wei, G., Wang, X., & Hua, F. (2023) · Aging and Disease · doi:10.14336/ad.2023.0727 · Cited by 72
“TGR5 receptors located on gut endocrine L cells in the ileum and colon are activated by different concentrations of BAs to secrete glucagon-like peptides, which promote the regeneration and repair of intestinal epithelial cells [46-48].”
BackgroundZhang, H., Xie, Y., Cao, F., & Song, X. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2382336 · Cited by 78
Bile acids and cardiovascular function in cirrhosis
Voiosu, A., Wiese, S., Voiosu, T., Bendtsen, F., & Møller, S. (2017) · Liver international (Print) · doi:10.1111/liv.13394 · Cited by 62
“44 The deleterious ef - fect of prolonged exposure of immune cells to increased levels of BAs indicatesthat they may be a mediator of the increased risk of infectious complications and endotoxemia frequently encountered in cirrhosis.”
BackgroundLiu, X., Chen, B., You, W., Xue, S., Qin, H., & Jiang, H. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.10.017 · Cited by 75
Lithocholic Acid Is a Vitamin D Receptor Ligand That Acts Preferentially in the Ileum
Ishizawa, M., Akagi, D., & Makishima, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19071975 · Cited by 72
“LCA activates other nuclear receptors, farnesoid X receptor and pregnane X receptor, as well as the G protein-coupled receptor, TGR5 [6,23,24,33,34].”
BackgroundBile acids drive colonic secretion of glucagon-like-peptide 1 and peptide-YY in rodents
Christiansen, C. B., Trammell, S. A. J., Wewer Albrechtsen, N. J., Schoonjans, K., Albrechtsen, R., Gillum, M. P., Kuhre, R. E., & Holst, J. J. (2019) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00010.2019 · Cited by 67
“Additionally, BAs stimulate the Takeda-G-protein-coupled70 receptor 5 (TGR5) (or G-protein-bile-acid-receptor-1) which activates Gαs-signaling increasing 71 intracellular cAMP levels (27, 28, 36, 60).”
BackgroundResultInfluentialCalmus, Y., & Poupon, R. (2014) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2014.07.007 · Cited by 69
Chevre, R., Trigueros‐Motos, L., Castaño, D., Chua, T., Corlianò, M., Patankar, J. V., Sng, L., Sim, L., Juin, T. L., Carissimo, G., et al. (2018) · The FASEB Journal · doi:10.1096/fj.201701084rr · Cited by 65
Biagioli, M., Carino, A., Fiorucci, C., Marchianò, S., Di Giorgio, C., Roselli, R., Magro, M., Distrutti, E., Bereshchenko, O., Scarpelli, P., et al. (2019) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2019.06.003 · Cited by 67
Nakada, E. M., Bhakta, N. R., Korwin-Mihavics, B. R., Kumar, A., Chamberlain, N., Bruno, S. R., Chapman, D. G., Hoffman, S. M., Daphtary, N., Aliyeva, M., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.98101 · Cited by 73
Role of Dietary Lipids in Modulating Inflammation through the Gut Microbiota
Wisniewski, P. J., Dowden, R. A., & Campbell, S. C. (2019) · Nutrients · doi:10.3390/nu11010117 · Cited by 71
“Studies also demonstrate that TGR5 exerts inflammatory control through the suppression of cytokine production following innate immune responses [151–153].”
BackgroundInfluentialPellicciari, R., Passeri, D., Franco, F., Mostarda, S., Filipponi, P., Colliva, C., Gadaleta, R. M., Franco, P., Carotti, A., Macchiarulo, A., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01126 · Cited by 72
Jena, P. K., Sheng, L., McNeil, K. D., Chau, T., Yu, S., Kiuru, M. H., Fung, M. A., Hwang, S. T., & Wan, Y. Y. (2019) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2019.05.007 · Cited by 69
Modulation of polycystic kidney disease by G-protein coupled receptors and cyclic AMP signaling
Sussman, C. R., Wang, X., Chebib, F. T., & Torres, V. E. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109649 · Cited by 72
Simultaneous inhibition of FXR and TGR5 exacerbates atherosclerotic formation
Miyazaki-Anzai, S., Masuda, M., Kohno, S., Levi, M., Shiozaki, Y., Keenan, A. L., & Miyazaki, M. (2018) · Journal of Lipid Research · doi:10.1194/jlr.m087239 · Cited by 63
“cytes such as macrophages (14), whereas FXR expression is low or undetectable in leukocytes (4, 16, 22).”
BackgroundDysregulated bile acid homeostasis: unveiling its role in metabolic diseases
Wang, Y., Xu, H., Zhou, X., Chen, W., & Zhou, H. (2024) · Medical Review · doi:10.1515/mr-2024-0020 · Cited by 74
Identification of surrogate ligands for orphan G protein-coupled receptors
Takeda, S., Yamamoto, A., Okada, T., 松村, 恵., Nose, E., Kogure, K., Kojima, S., & Haga, T. (2003) · Life Sciences · doi:10.1016/j.lfs.2003.09.030 · Cited by 70
Schumacher, J. D., & Guo, G. L. (2019) · Handbook of experimental pharmacology · doi:10.1007/164_2019_228 · Cited by 67
Huang, S., Ma, S.-Y., Ning, M., Yang, W., Ye, Y., Zhang, L., Shen, J., & Leng, Y. (2019) · Metabolism · doi:10.1016/j.metabol.2019.07.003 · Cited by 65
Gut Microbiota in Liver Disease: What Do We Know and What Do We Not Know?
Jiang, L., & Schnabl, B. (2020) · Physiology · doi:10.1152/physiol.00005.2020 · Cited by 77
Gut microbiome and metabolites, the future direction of diagnosis and treatment of atherosclerosis?
Cao, H., Zhu, Y., Hu, G., Zhang, Q., & Zheng, L. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106586 · Cited by 68
Role of Vitamin D Receptor in the Lithocholic Acid-Mediated CYP3A Induction in Vitro and in Vivo
Matsubara, T., Yoshinari, K., Aoyama, K., Sugawara, M., Sekiya, Y., Nagata, K., & Yamazoe, Y. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.021501 · Cited by 73
“, 2002) and G protein-coupled plasma membrane receptor TGR5 (Kawamata et al., 2003).”
BackgroundMurakami, S., Fujita, M., Nakamura, M., Sakono, M., Nishizono, S., Sato, M., Imaizumi, K., Mori, M., & Fukuda, N. (2015) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12534 · Cited by 64
“The nuclear receptor FXR and the G-protein-coupled receptor TGR5 were recently discovered and their roles in lipid, glucose and energy metabolism have been vigorously studied.6,14 Affinity for TGR5 varies according to the type of bile acid, with taurineconjugated bile acids having a relatively high affinity for TGR5.”
BackgroundInfluentialLasalle, M., Hoguet, V., Hennuyer, N., Leroux, F., Piveteau, C., Belloy, L., Lestavel, S., Vallez, E., Dorchies, E., Duplan, I., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01873 · Cited by 61
Zhao, S., Gong, Z., Du, X., Tian, C., Wang, L., Zhou, J., Xu, C., Chen, Y., Cai, W., & Wu, J. (2018) · Journal of Immunology Research · doi:10.1155/2018/2481418 · Cited by 68
The Effect of Lithocholic Acid on the Gut-Liver Axis
Sheng, W., Ji, G., & Zhang, L. R. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.910493 · Cited by 69
Kotarsky, K., Nilsson, N. E., Olde, B., & Owman, C. (2003) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.2003.pto930601.x · Cited by 71
“They have been applied to the process of ‘‘de-orphanization’’, as primary or secondary screening tools (Briscoe et al. 2003; Kawamata et al. 2003).”
MethodTherapeutic potential of Takeda‐ G ‐protein‐receptor‐5 ( TGR5 ) agonists. Hope or hype?
Hodge, R. J., & Nunez, D. J. (2016) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12636 · Cited by 63
“Further complicating this picture is an evolving recognition that there may be significant interplay between gender and the gut microbiome [36], which may be pertinent since secondary bile acids generated by gut bacteria are potent endogenous ligands for the TGR5 receptor [1].”
BackgroundAo, M., Sarathy, J., Domingue, J., Alrefai, W. A., & Rao, M. C. (2013) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00416.2012 · Cited by 62
“More recently, the GPCR TGR5, also known as GPBAR-1, M-BAR, BG37, GPCR19, or GPR131, has been reported to be widely distributed in human tissues, including most segments of the digestive tract with the exception of the esophagus and rectum (19, 24).”
BackgroundMolecular aspects of medicine: from experimental to clinical hepatology
Häussinger, D., Kubitz, R., Reinehr, R., Bode, J. G., & Schliess, F. (2004) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2004.02.001 · Cited by 66
Camilleri, M., Shin, A., Busciglio, I., Carlson, P., Acosta, A., Bharucha, A. E., Burton, D., Lamsam, J., Lueke, A., Donato, L. J., et al. (2014) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00178.2014 · Cited by 60
Nutritional lipidomics: Molecular metabolism, analytics, and diagnostics
Smilowitz, J. T., Zivkovic, A. M., Wan, Y. Y., Watkins, S. M., Nording, M. L., Hammock, B. D., & German, J. B. (2013) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201200808 · Cited by 64
Carino, A., Graziosi, L., D’Amore, C., Cipriani, S., Marchianò, S., Marino, E., Zampella, A., Rende, M., Mosci, P., Distrutti, E., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10477 · Cited by 65
“litocholic acid (LCA) and deoxycholic acid (DCA) and their tauro- and glyco-conjugated forms) GPBAR1 modulates multiple targets by genomic and non-genomic effects [9, 10].”
BackgroundCholesterol cholelithiasis: part of a systemic metabolic disease, prone to primary prevention
Ciaula, A. D., Wang, D. Q. ‐., & Portincasa, P. (2018) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2019.1549988 · Cited by 67
The role of bile acid receptor TGR5 in regulating inflammatory signalling
Ye, D., He, J., & He, X. (2024) · Scandinavian Journal of Immunology · doi:10.1111/sji.13361 · Cited by 73
Kostenis, E. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.04.005 · Cited by 66
Role of Intestinal Microbiome in Lipid and Glucose Metabolism in Diabetes Mellitus
van Olden, C. C., Groen, A. K., & Nieuwdorp, M. (2015) · Clinical Therapeutics · doi:10.1016/j.clinthera.2015.03.008 · Cited by 66
Burrin, D. G., Stoll, B., & Moore, D. D. (2013) · Journal of Animal Science · doi:10.2527/jas.2013-6331 · Cited by 68
“The second major bile acid receptor characterized in recent years is the G protein coupled membrane receptor (GPCR), TGR5, also known as G protein-coupled bile acid receptor 1 (GPBAR 1), or GPR131 (Kawamata et al., 2003; Thomas et al., 2008).”
BackgroundThe Gut Microbial Endocrine Organ in Type 2 Diabetes
Massey, W. J., & Brown, J. M. (2020) · Endocrinology · doi:10.1210/endocr/bqaa235 · Cited by 67
“A small portion reaches the lower intestinal tract where microbes cleave the glycine or taurine and either reduce or epimerize the 7-hydroxy group to make the secondary bile acids (2BAs): deoxycholic acid (DCA), lithocholic acid (LCA), and ursodeoxycholic acid (UDCA), which can then be absorbed into portal circulation…”
BackgroundBidault, V., Merlen, G., Glénisson, M., Doignon, I., Garcin, I., Pean, N., Boisgard, R., Bedoya, J. U., Sérino, M., Ullmer, C., et al. (2020) · JHEP Reports · doi:10.1016/j.jhepr.2020.100214 · Cited by 61
Metadata
- Authors
- Kawamata, Y., Fujii, R., Hosoya, M., Harada, M., Yoshida, H., Miwa, M., Fukusumi, S., Habata, Y., Itoh, T., Shintani, Y., Hinuma, S., Fujisawa, Y., & Fujino, M.
- Affiliations
- Takeda (Japan) (JP)
- Corresponding author
- Hinuma, Shuji
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-03
- Volume
- 278
- Issue
- 11
- Pages
- 9435-9440
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2096418655
- Cited by
- 1,628
- References
- 27
- Citations by year
- 2026: 96 · 2025: 90 · 2024: 114 · 2023: 122 · 2022: 101 · 2021: 114 · 2020: 100 · 2019: 99 · 2018: 108 · 2017: 99 · 2016: 77 · 2015: 76 · 2014: 71 · 2013: 75 · 2012: 50
- FWCI
- 6.99
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6433 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Keywords
- TGR5, G protein-coupled receptors, bile acids, cell surface receptors, receptor internalization, ERK MAP kinase, cAMP production, macrophages, monocytes, phagocytosis, cytokine production, lipopolysaccharide, THP-1 cells, alveolar macrophages
- MeSH terms
- Cyclic AMP, Amino Acid Sequence, Animals, Bile Acids and Salts, Cell Line, Cell Membrane, Dose-Response Relationship, Drug, Genetic Vectors, Cricetinae, Humans, Luminescent Proteins, Macrophages, Molecular Sequence Data, Phagocytosis, Protein Binding, Rabbits, Receptors, Cell Surface, Recombinant Fusion Proteins, RNA, Messenger, Time Factors, Tissue Distribution, Transfection, Cytokines, Guanosine 5'-O-(3-Thiotriphosphate), CHO Cells, GTP-Binding Proteins, Reverse Transcriptase Polymerase Chain Reaction, Mitogen-Activated Protein Kinases, MAP Kinase Signaling System, Receptors, G-Protein-Coupled, Green Fluorescent Proteins, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.